Jonathan A. Cosin

3.3k total citations
26 papers, 686 citations indexed

About

Jonathan A. Cosin is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Jonathan A. Cosin has authored 26 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Obstetrics and Gynecology, 13 papers in Reproductive Medicine and 12 papers in Surgery. Recurrent topics in Jonathan A. Cosin's work include Endometrial and Cervical Cancer Treatments (14 papers), Ovarian cancer diagnosis and treatment (11 papers) and Uterine Myomas and Treatments (5 papers). Jonathan A. Cosin is often cited by papers focused on Endometrial and Cervical Cancer Treatments (14 papers), Ovarian cancer diagnosis and treatment (11 papers) and Uterine Myomas and Treatments (5 papers). Jonathan A. Cosin collaborates with scholars based in United States, Canada and Spain. Jonathan A. Cosin's co-authors include Linda F. Carson, Leo B. Twiggs, Pamela J. Paley, Jeffrey M. Fowler, Jeffrey D. Seidman, Anna Yemelyanova, Charles R. Boice, Michael A. Bidus, Daniel R. Grow and A. Bayes de Luna and has published in prestigious journals such as Circulation, Cancer and Cancer Research.

In The Last Decade

Jonathan A. Cosin

25 papers receiving 667 citations

Peers

Countries citing papers authored by Jonathan A. Cosin

Since Specialization

Citations

This map shows the geographic impact of Jonathan A. Cosin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan A. Cosin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan A. Cosin more than expected).

Fields of papers citing papers by Jonathan A. Cosin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan A. Cosin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan A. Cosin. The network helps show where Jonathan A. Cosin may publish in the future.

Co-authorship network of co-authors of Jonathan A. Cosin

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan A. Cosin. A scholar is included among the top collaborators of Jonathan A. Cosin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan A. Cosin. Jonathan A. Cosin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First-line pembrolizumab used concurrently with multi-agent chemotherapy and inhaled tranexamic acid (TXA) for management of stage III mixed trophoblastic tumor complicated by pulmonary hemorrhage 2025 ·Gynecologic Oncology Reports ·(unknown), (unknown), Amy Brown, (unknown), Jonathan A. Cosin, (unknown), (unknown)	0
2	A Phase I Evaluation of Extended Field Radiation Therapy With Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women With Cervical Carcinoma Metastatic to the Para-aortic Lymph Nodes: An NRG Oncology/Gynecologic Oncology Group Study 2018 ·Gynecologic Oncology ·Cecelia H. Boardman, William E. Brady, Don S. Dizon, Charles A. Kunos, Kathleen N. Moore, Kristine Zanotti, (unknown), Jonathan A. Cosin, Carol Aghajanian, Paula M. Fracasso	13
3	Controversies in Gynecologic Cancer Staging: An AJCC Cancer Staging Manual, Eighth Edition Perspective 2018 ·Ian S. Hagemann, (unknown), Jonathan A. Cosin, Donna M. Gress, David G. Mutch, Alexander Olawaiye	1
4	Complications of Robotic Gynecologic Surgery in the Severely Morbidly Obese 2016 ·Annals of Surgical Oncology ·Jonathan A. Cosin, (unknown), (unknown), Hong‐Bin Fang	14
5	Survival Rates for International Federation of Gynecology and Obstetrics Stage III Ovarian Carcinoma by Cell Type 2012 ·International Journal of Gynecological Cancer ·Jeffrey D. Seidman, Anna Yemelyanova, Jonathan A. Cosin, Anthony Y. Smith, Robert J. Kurman	33
6	Upstaging pathologic stage I ovarian carcinoma based on dense adhesions is not warranted: A clinicopathologic study of 84 patients originally classified as FIGO stage II 2010 ·Gynecologic Oncology ·Jeffrey D. Seidman, Jonathan A. Cosin, Brant G. Wang, (unknown), Anna Yemelyanova, Abbie L. Fields, Charles R. Boice, Richard J. Zaino	7
7	Prognostic Factors for Stage I Ovarian Carcinoma 2009 ·International Journal of Gynecological Pathology ·Jeffrey D. Seidman, Anna Yemelyanova, (unknown), Michael A. Bidus, Louis A. Dainty, Charles R. Boice, Jonathan A. Cosin	22
8	The ability of endometrial biopsies with atypical complex hyperplasia to guide surgical management 2008 ·American Journal of Obstetrics and Gynecology ·Caela Miller, Michael A. Bidus, (unknown), G. Larry Maxwell, Jonathan A. Cosin, G. Scott Rose	13
9	Modulation of Angiogenic Phenotype Alters Tumorigenicity in Rat Ovarian Epithelial Cells 2007 ·Cancer Research ·(unknown), Ruud P.M. Dings, Jonathan A. Cosin, Indira V. Subramanian, Nelly Auersperg, Sundaram Ramakrishnan	29
10	Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening 2007 ·International Journal of Gynecological Cancer ·Anna Yemelyanova, Jonathan A. Cosin, Michael A. Bidus, Charles R. Boice, Jeffrey D. Seidman	26
11	Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum 2006 ·Gynecologic Oncology ·Jeffrey D. Seidman, Iren Horkayne‐Szakaly, Jonathan A. Cosin, (unknown), (unknown), Charles R. Boice, Anna Yemelyanova	60
12	Hematologic changes after splenectomy for cytoreduction: implications for predicting infection and effects on chemotherapy 2006 ·International Journal of Gynecological Cancer ·Michael A. Bidus, Thomas C. Krivak, Robert Howard, G. Scott Rose, Jonathan A. Cosin, Louis A. Dainty, John C. Elkas	17
13	Carcinomas of the Female Genital Tract Occurring After Pelvic Irradiation 2006 ·International Journal of Gynecological Pathology ·Jeffrey D. Seidman, Dhruv Kumar, Jonathan A. Cosin, William E. Winter, (unknown), Charles R. Boice	10
14	Stage IV Carcinoma of the Bartholin Gland Managed with Primary Chemoradiation 2002 ·Gynecologic Oncology ·Levi S. Downs, Kris Ghosh, Kathryn E. Dusenbery, Jonathan A. Cosin	16
15	Phase II Study of Mitomycin, Doxorubicin, and Cisplatin in the Treatment of Advanced Uterine Leiomyosarcoma: A Gynecologic Oncology Group Study 2002 ·Gynecologic Oncology ·John H. Edmonson, John A. Blessing, Jonathan A. Cosin, David S. Miller, David E. Cohn, Jacob Rotmensch	27
16	Pretreatment surgical staging of patients with cervical carcinoma 1998 ·Cancer ·Jonathan A. Cosin, Jeffrey M. Fowler, (unknown), Pamela J. Paley, Linda F. Carson, Leo B. Twiggs	165
17	The Effect of Sartorius Transposition on Wound Morbidity Following Inguinal–Femoral Lymphadenectomy 1997 ·Gynecologic Oncology ·Pamela J. Paley, Peter R. Johnson, Leon L. Adcock, Jonathan A. Cosin, (unknown), Jeffrey M. Fowler, Leo B. Twiggs, Linda F. Carson	40
18	The use of methotrexate and arterial embolization to avoid surgery in a case of cervical pregnancy 1997 ·Fertility and Sterility ·Jonathan A. Cosin, (unknown), Daniel R. Grow, (unknown)	44
19	A Simplified Method for Detubularization in the Construction of a Continent Ileocolic Reservoir (Miami Pouch) 1997 ·Gynecologic Oncology ·Jonathan A. Cosin, Jonathan Carter, Pamela J. Paley, (unknown), Peter R. Johnson, Jeffrey M. Fowler, Leo B. Twiggs, Linda F. Carson	2
20	The Safety and Efficacy of Extensive Abdominal Panniculectomy at the Time of Pelvic Surgery 1994 ·Gynecologic Oncology ·Jonathan A. Cosin, John L. Powell, (unknown), (unknown)	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact